- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
RFA offers option for ovarian cancer metastases in liver
Radiofrequency ablation is effective for treating some liver metastases of ovarian cancer and could spare patients from repeated surgeries, according to a retrospective study from Massachusetts General Hospital.
Radiofrequency ablation is effective for treating some liver metastases of ovarian cancer and could spare patients from repeated surgeries, according to a retrospective study from Massachusetts General Hospital.
"Some studies have shown that patients with advanced ovarian cancer can survive longer if they have repeated surgery to remove recurrent or new disease," said lead author Dr. Debra Gervais. "We wanted to see if we could use RF ablation instead of repeated open surgical resection for some of these patients."
The study, published in the American Journal of Roentgenology in September, examined results for six patients with stage III and stage IV ovarian cancer that had metastasized to the liver.
The patients, who were treated consecutively over a six-year period at the Boston hospital, had six tumors: Five were solitary metastatic lesions, and one was a dominant liver mass in the small soft-tissue peritoneal nodule. Five tumors were along the periphery of the liver, and the sixth was intraparenchymal (stage IV). Mean tumor diameter was 2.7 cm.
Postablation, results were regularly assessed and monitored with contrast-enhanced CT and, in some cases, FDG-PET for up to 3.3 years.
The study concluded that one RFA treatment completely eliminated the tumor in five of six patients. Of the five patients who were treated successfully, one showed recurrence on FDG-PET scans nine months after treatment and required a second ablation procedure, which was successful.
Although the treatment was successful in five cases, new tumors developed apart from the target site, and patients required other treatments such as surgery and chemotherapy.
The authors concluded there is a role for RFA in some cases to achieve local control.
For more information from the Diagnostic Imaging archives:
RFA and cryoablation expand treatment of hepatic tumors
False positives foil hopes for ovarian cancer screening
Genetic findings affect diagnosis, treatment of ovarian cancer
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
